NEW YORK (GenomeWeb) – CombiMatrix today announced the New York State Department of Health (NYSDOH) has granted the firm conditional approval for its array-based test for pre-implantation genetic screening (PGS).

The CombiPGS test is intended for women undergoing pre-implantation genetic screening for chromosomal abnormalities during in vitro fertilization.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.